Product
CCS1477
2 clinical trials
10 indications
Indication
Breast CancerIndication
Lung CancerIndication
CancerIndication
Haematological MalignancyIndication
Acute Myeloid LeukemiaIndication
Non-Hodgkin LymphomaIndication
Multiple MyelomaIndication
Myelodysplastic SyndromeIndication
Peripheral T Cell LymphomaClinical trial
An Open-label Phase I/IIa Study to Evaluate the Safety and Efficacy of CCS1477 as Monotherapy and in Combination, in Patients With Advanced Solid/Metastatic Tumours.Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
An Open-label Phase I/IIa Study to Evaluate the Safety and Efficacy of CCS1477 as Monotherapy and in Combination in Patients With Advanced Haematological Malignancies.Status: Recruiting, Estimated PCD: 2025-06-30